Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
After finishing at $78.84 in the prior trading day, Procept BioRobotics Corp (NASDAQ: PRCT) closed at $76.02, down -3.58%. In other words, the price has decreased by -$3.58 from its previous closing price. On the day, 0.98 million shares were traded. PRCT stock price reached its highest trading level at $79.26 during the session, while it also had its lowest trading level at $75.75.
Ratios:
Our goal is to gain a better understanding of PRCT by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.07 and its Current Ratio is at 6.02. In the meantime, Its Debt-to-Equity ratio is 0.33 whereas as Long-Term Debt/Eq ratio is at 0.33.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Morgan Stanley on December 02, 2024, initiated with a Overweight rating and assigned the stock a target price of $105.
On November 14, 2024, Jefferies started tracking the stock assigning a Hold rating and target price of $95.
On August 11, 2023, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $42.Piper Sandler initiated its Overweight rating on August 11, 2023, with a $42 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Dec 04 ’24 when Zadno Reza sold 26,423 shares for $97.22 per share. The transaction valued at 2,568,844 led to the insider holds 152,762 shares of the business.
Nouri Alaleh sold 28,092 shares of PRCT for $2,728,574 on Dec 04 ’24. The EVP, CLO, CORP. SEC. now owns 52,472 shares after completing the transaction at $97.13 per share. On Dec 04 ’24, another insider, REZA ZADNO, who serves as the Director of the company, bought 26,423 shares for $96.48 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PRCT now has a Market Capitalization of 4113160704 and an Enterprise Value of 3852841728. For the stock, the TTM Price-to-Sale (P/S) ratio is 20.69 while its Price-to-Book (P/B) ratio in mrq is 16.43. Its current Enterprise Value per Revenue stands at 19.279 whereas that against EBITDA is -38.011.
Stock Price History:
The Beta on a monthly basis for PRCT is 1.05, which has changed by 0.62923276 over the last 52 weeks, in comparison to a change of 0.23631513 over the same period for the S&P500. Over the past 52 weeks, PRCT has reached a high of $103.81, while it has fallen to a 52-week low of $44.02. The 50-Day Moving Average of the stock is -14.91%, while the 200-Day Moving Average is calculated to be 4.26%.
Shares Statistics:
The stock has traded on average 804.81K shares per day over the past 3-months and 748660 shares per day over the last 10 days, according to various share statistics. A total of 52.15M shares are outstanding, with a floating share count of 51.55M. Insiders hold about 5.23% of the company’s shares, while institutions hold 85.72% stake in the company. Shares short for PRCT as of 1735603200 were 6885494 with a Short Ratio of 8.56, compared to 1732838400 on 6090551. Therefore, it implies a Short% of Shares Outstanding of 6885494 and a Short% of Float of 17.21.
